DealAnagram Therapeutics, a Natick, MA-based clinical-stage biopharma company, raised $250 million in a growth equity investment led by Blackstone Life Sciences with participation from Cystic Fibrosis Foundation.
More on VC News Daily →
OTHER
05/11/2026
Aumet, a Riyadh, Saudi Arabia-based healthtech platform for MENA, raised...
CREATE Medicines, a Cambridge, MA-based clinical-stage CAR-T developer,...
9amHealth, an Encinitas, CA-based virtual chronic care platform, raised...
XCaliber Health, an Andover, MA-based agentic OS for healthcare, raised...
SageOx, a Seattle-based AI agent collaboration platform, raised $15...
Rosarium Health, a U.S.-based aging-at-home healthcare platform, raised $6...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
